ANVISA update - will mandatory review on pharma patent cases continue?

The working requirements under Brazil’s patent law oblige the patentee/licensee to manufacture/ produce/assemble the patented product locally. This is inconsistent with Article 27.1 of the TRIPS Agreement, which states that patents shall be available and patent rights enjoyable without discrimination as to the place of invention, the field of technology and whether products are imported or locally produced.